XML 134 R93.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Financial Instruments and Risk Management - Marketable securities (Details) | Oct. 31, 2021 CAD ($) | Nov. 18, 2020 CAD ($) EquityInstruments
--- | --- | ---
Pathway Health Corp |  |
Disclosure of nature and extent of risks arising from financial instruments [line items] |  |
Marketable securities |  | $ 225,000
Meta Growth Corp |  |
Disclosure of nature and extent of risks arising from financial instruments [line items] |  |
Number of units of equity issued as part of consideration for business combination | EquityInstruments |  | 196,063,610
Marketable securities |  | $ 635,000
Meta Growth Corp | THC Global Group Limited |  |
Disclosure of nature and extent of risks arising from financial instruments [line items] |  |
Number of units of equity issued as part of consideration for business combination |  | 2,996,612
Marketable securities |  | $ 360,000
Meta Growth Corp | Pathway Health Corp |  |
Disclosure of nature and extent of risks arising from financial instruments [line items] |  |
Number of units of equity issued as part of consideration for business combination |  | 400,000
Marketable securities |  | $ 200,000
Fair value of marketable securities | $ 96,000 |

X
- Definition The fair value amount marketable securities. + References No definition available. + Details
Name: | hiti_FairValueOfMarketableSecurities
Namespace Prefix: | hiti_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount recognised as of the acquisition date for marketable securities acquired in a business combination. + References No definition available. + Details
Name: | hiti_MarketableSecuritiesRecognisedAsOfAcquisitionDate
Namespace Prefix: | hiti_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2021-01-01 -Paragraph B64 -Subparagraph f -Clause iv -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B -URIDate 2021-03-24 + Details
Name: | ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_CounterpartiesAxis=hiti_PathwayHealthCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=hiti_MetaGrowthCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=hiti_THCGlobalGroupLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |